This book, now in a revised and updated second edition, reviews the imaging-relevant features of selected classes of pharmaceuticals and drugs regarding CNS and head and neck images. The agents discussed belong to classes like Drugs and Alcohol; Contrast Agents; Chemotherapy; Immunotherapy; Antibiotics, Antiviral Agents, and Vaccines; Antiepilectic and Antipsychotic Agents; and Hematologic Agents, each of which is addressed in a separate chapter. The book’s closing part addresses agents from various other classes.
For each class, concise texts and rich images review and illustrate the mechanism of action. All chapters from the previous edition have been extensively updated, and new chapters on certain pharmaceuticals have been added. Highlighting the implications of these agents for imaging findings, the book offers an excellent resource for neuroradiologists and clinicians alike.
Author(s): Daniel Thomas Ginat, Juan E. Small, Pamela Whitney Schaefer
Edition: 2
Publisher: Springer
Year: 2022
Language: English
Pages: 412
City: Cham
Contents
Part I: Drugs and Alcohol
1: Tobacco
1.1 Uses
1.2 Mechanism
1.3 Imaging Findings
1.3.1 Stroke
1.3.2 Cerebral Aneurysm
1.3.3 Cerebral Venous Thrombosis
1.3.4 Head and Neck Cancer, Squamous Cell Carcinoma
1.3.5 Brain Metastases
1.3.6 Warthin Tumor
1.3.7 Smoking-Induced Nasopharyngeal Lymphoid Hyperplasia
Suggested Reading
2: Alcohol
2.1 Uses
2.2 Mechanism
2.3 Imaging Findings
Suggested Reading
3: Methanol
3.1 Uses
3.2 Mechanism
3.3 Imaging Findings
3.4 Differential Diagnosis
Suggested Reading
4: Cannabis (Marijuana)
4.1 Uses
4.2 Mechanism
4.3 Imaging Findings
4.4 Differential Diagnosis
Suggested Reading
5: Synthetic Cannabinoids
5.1 Uses
5.2 Mechanism
5.3 Imaging Findings
5.4 Differential Diagnosis
Suggested Reading
6: Crack and Cocaine
6.1 Uses
6.2 Mechanism
6.3 Imaging Findings
6.4 Differential Diagnosis
Suggested Reading
7: Amphetamines
7.1 Uses
7.2 Mechanism
7.3 Imaging Findings
7.4 Differential Diagnosis
Suggested Reading
8: Opioids
8.1 Uses
8.2 Mechanism
8.3 Imaging Findings
8.4 Differential Diagnosis
Suggested Reading
9: Betel Nuts
9.1 Uses
9.2 Mechanism
9.3 Imaging Findings
9.4 Differential Diagnosis
Suggested Reading
10: Licorice
10.1 Uses
10.2 Mechanism
10.3 Imaging Findings
10.4 Differential Diagnosis
Suggested Reading
11: Centella asiatica
11.1 Uses
11.2 Mechanism
11.3 Imaging Findings
11.4 Differential Diagnosis
Suggested Reading
Part II: Contrast Agents
12: Iodinated Contrast Agents
12.1 Uses
12.2 Mechanism
12.3 Imaging Findings
12.4 Differential Diagnosis
Suggested Reading
13: Gadolinium-Based Contrast Agents
13.1 Uses
13.2 Mechanism
13.3 Imaging Findings
13.4 Differential Diagnosis
Suggested Reading
14: Ferumoxytol
14.1 Uses
14.2 Mechanism of Action
14.3 Imaging Findings
14.4 Differential Diagnosis
Suggested Reading
15: Pantopaque (Myodil, Iodophenylundecylic Acid)
15.1 Uses
15.2 Mechanism
15.3 Imaging Findings
15.4 Differential Diagnosis
Suggested Reading
16: Thorium Dioxide (Thorotrast)
16.1 Uses
16.2 Mechanism
16.3 Imaging Findings
16.4 Differential Diagnosis
Suggested Reading
Part III: Chemotherapy
17: Temozolamide (Temodar)
17.1 Uses
17.2 Mechanism
17.3 Imaging Findings
17.4 Differential Diagnosis
Suggested Reading
18: 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (BCNU; Carmustine) Polymer Wafer (Gliadel)
18.1 Uses
18.2 Mechanism
18.3 Imaging Findings
18.4 Differential Diagnosis
Suggested Reading
19: Methotrexate
19.1 Uses
19.2 Mechanism
19.3 Imaging Findings
19.4 Differential Diagnosis
Suggested Reading
20: 5-Fluorouracil
20.1 Uses
20.2 Mechanism
20.3 Imaging Findings
20.4 Differential Diagnosis
Suggested Reading
21: l-Asparaginase (Elspar/Erwinase)
21.1 Uses
21.2 Mechanism
21.3 Imaging Findings
21.4 Differential Diagnosis
Suggested Reading
22: Calcineurin Inhibitors
22.1 Uses
22.2 Mechanism
22.3 Imaging Findings
22.4 Differential Diagnosis
Suggested Reading
23: Bromocriptine (Parlodel) and Cabergoline (Dostinex)
23.1 Uses
23.2 Mechanism
23.3 Imaging Findings
23.4 Differential Diagnosis
Suggested Reading
24: HiDAC (High-Dose Ara-C; Cytarabine; Cytosine Arabinoside; Cytosar-U; Depocyt)
24.1 Uses
24.2 Mechanism
24.3 Imaging Findings
24.4 Differential Diagnosis
Suggested Reading
Part IV: Anti-Cancer Immunotherapy
25: Ipilimumab (MDX-010, Yervoy)
25.1 Uses
25.2 Mechanism
25.3 Imaging Findings
25.4 Differential Diagnosis
Suggested Reading
26: Bevacizumab (Avastin)
26.1 Uses
26.2 Mechanism
26.3 Imaging Findings
26.4 Differential Diagnosis
Suggested Reading
27: Chimeric Antigen Receptor T-Cell Therapy (Tisagenlecleucel and Axicabtagene Ciloleucel)
27.1 Uses
27.2 Mechanism
27.3 Imaging Findings
27.4 Differential Diagnosis
Suggested Reading
Part V: Antibiotics, Antiviral Agents, and Vaccines
28: Metronidazole (Flagyl)
28.1 Uses
28.2 Mechanism
28.3 Imaging Findings
28.4 Differential Diagnosis
Suggested Reading
29: Iodoform
29.1 Uses
29.2 Mechanism
29.3 Imaging Findings
29.4 Differential Diagnosis
Suggested Reading
30: Isoniazid
30.1 Uses
30.2 Mechanism
30.3 Imaging Findings
30.4 Differential Diagnosis
Suggested Reading
31: Highly Active Antiretroviral Therapy (HAART)
31.1 Uses
31.2 Mechanism
31.3 Imaging Findings
31.4 Differential Diagnosis
Suggested Reading
32: Vaccines
32.1 Uses
32.2 Mechanism
32.3 Discussion
32.4 Differential Diagnosis
Suggested Reading
Part VI: Antiepilectic, Antipsychotic, and General Anesthetic Agents
33: Dilantin (Phenytoin Sodium)
33.1 Uses
33.2 Mechanism
33.3 Imaging Findings
33.4 Differential Diagnosis
Suggested Reading
34: Valproic Acid (Sodium Valproate, Depakote)
34.1 Uses
34.2 Mechanism
34.3 Imaging Findings
34.4 Differential Diagnosis
Suggested Reading
35: Vigabatrin (Sabril)
35.1 Uses
35.2 Mechanism
35.3 Imaging Findings
35.4 Differential Diagnosis
Suggested Reading
36: Lithium
36.1 Uses
36.2 Mechanism
36.3 Imaging Findings
36.4 Differential Diagnosis
Suggested Reading
37: Neuroleptics
37.1 Uses
37.2 Mechanism
37.3 Imaging Findings
37.4 Differential Diagnosis
Suggested Reading
Part VII: Anesthetic and Sedative Agents
38: Barbiturates (Pentobarbital)
38.1 Uses
38.2 Mechanism
38.3 Imaging Findings
Suggested Reading
39: Nitrous Oxide (N2O)
39.1 Uses
39.2 Mechanism
39.3 Imaging Findings
39.4 Differential Diagnosis
Suggested Reading
40: Propofol
40.1 Uses
40.2 Mechanism
40.3 Imaging Findings
40.4 Differential Diagnosis
Suggested Reading
Part VIII: Hemostatic and Vasoactive Agents
41: Embolic Agents
41.1 Uses
41.2 Mechanism
41.3 Imaging Findings
41.4 Differential Diagnosis
Suggested Reading
42: Aspirin and Plavix/Clopidogrel
42.1 Uses
42.2 Mechanism
42.3 Imaging Findings
42.4 Differential Diagnosis
Suggested Reading
43: Warfarin (Coumadin)
43.1 Uses
43.2 Mechanism
43.3 Imaging Findings
43.4 Differential Diagnosis
Suggested Reading
44: Heparin
44.1 Uses
44.2 Mechanism
44.3 Imaging Findings
44.4 Differential Diagnosis
Suggested Reading
45: Tissue Plasminogen Activator (tPA)
45.1 Uses
45.2 Mechanism
45.3 Imaging Findings
45.4 Differential Diagnosis
Suggested Reading
46: Oxidized Cellulose
46.1 Uses
46.2 Mechanism
46.3 Imaging Findings
46.4 Differential Diagnosis
Suggested Reading
47: Nasal Decongestants
47.1 Uses
47.2 Mechanism
47.3 Imaging Findings
47.4 Differential Diagnosis
Suggested Reading
Part IX: Cardiovascular Support Agents
48: Supplemental Oxygen
48.1 Uses
48.2 Mechanism
48.3 Imaging Findings
48.4 Differential Diagnosis
Suggested Reading
49: Hypertonic Saline
49.1 Uses
49.2 Mechanism
49.3 Imaging Findings
49.4 Differential Diagnosis
Suggested Reading
50: Mannitol (1,2,3,4,5, 6-Hexanehexol)
50.1 Uses
50.2 Mechanism
50.3 Imaging Findings
50.4 Differential Diagnosis
Suggested Reading
51: Triple H Therapy
51.1 Uses
51.2 Mechanism
51.3 Imaging Findings
51.4 Differential Diagnosis
Suggested Reading
52: Angiotensin-Converting Enzyme (ACE) Inhibitors
52.1 Uses
52.2 Mechanism
52.3 Imaging Findings
52.4 Differential Diagnosis
Suggested Reading
53: Acetazolamide (Diamox)
53.1 Uses
53.2 Mechanism
53.3 Imaging Findings
53.4 Differential Diagnosis
Suggested Reading
54: Amiodarone
54.1 Uses
54.2 Mechanism
54.3 Imaging Findings
54.4 Differential Diagnosis
Suggested Reading
Part X: Anti-Inflammatory Agents
55: Acetominophen (Tylenol, Paracetamol)
55.1 Uses
55.2 Mechanism
55.3 Imaging Findings
55.4 Differential Diagnosis
Suggested Reading
56: Natalizumab (Tysabri, Biogen Idec and Elan Pharmaceuticals)
56.1 Uses
56.2 Mechanism
56.3 Imaging Findings
56.4 Differential Diagnosis
Suggested Reading
57: Synthetic Corticosteroids
57.1 Uses
57.2 Mechanism
57.3 Imaging Findings
57.4 Differential Diagnosis
Suggested Reading
Part XI: Dietary Supplements, Homeostatic Agents, and Hormone-Like Drugs
58: Manganese in Total Parenteral Nutrition
58.1 Uses
58.2 Mechanism
58.3 Imaging Findings
58.4 Differential Diagnosis
Suggested Reading
59: Zinc Oxide (ZnO)
59.1 Uses
59.2 Mechanism
59.3 Imaging Findings
59.4 Differential Diagnosis
Suggested Reading
60: Insulin
60.1 Uses
60.2 Mechanism
60.3 Imaging Findings
60.4 Differential diagnosis
Suggested Reading
61: Bisphosphonates
61.1 Uses
61.2 Mechanism
61.3 Imaging Findings
61.4 Differential Diagnosis
Suggested Reading
62: Recombinant Human Bone Morphogenetic Protein
62.1 Uses
62.2 Mechanism
62.3 Imaging Findings
62.4 Differential Diagnosis
Suggested Reading
63: Retinoids (13-Cis-Retinoic Acid, Isotretinoin, Accutane, All-Trans-Retinoic Acid)
63.1 Uses
63.2 Mechanism
63.3 Imaging Findings
63.4 Differential Diagnosis
Suggested Reading
64: Topical Prostaglandin Analogs
64.1 Uses
64.2 Mechanism
64.3 Imagin Findings
64.4 Differential Diagnosis
Suggested Reading
65: Oral Contraceptives (Estrogen and Progestin)
65.1 Uses
65.2 Mechanism
65.3 Imaging Findings
65.4 Differential Diagnosis
Suggested Reading
66: Fish Oil
66.1 Uses
66.2 Mechanism
66.3 Imaging Findings
66.4 Differential Diagnosis
Suggested Reading
Part XII: Injectable Filler Agents
67: Calcium Hydroxyapatite–Based Fillers
67.1 Uses
67.2 Mechanism
67.3 Imaging Findings
67.4 Differential Diagnosis
Suggested Reading
68: Hyaluronic Acid–Based Fillers
68.1 Uses
68.2 Mechanism
68.3 Imaging Findings
68.4 Differential Diagnosis
Suggested Reading
69: Injectable Silicone Oil
69.1 Uses
69.2 Mechanism
69.3 Imaging Findings
69.4 Differential Diagnosis
Suggested Reading
